STOCK TITAN

MiniMed Group (MMED) CEO has 31,350 shares withheld for tax

(Very High)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Dallara Que, Chief Executive Officer of MiniMed Group, Inc., reported a tax-withholding disposition of 31,350 shares of Common Stock on July 31, 2026 at $18.15 per share. The shares were withheld by the company to satisfy RSU-related tax obligations. Que now directly holds 884,749 shares, including shares issuable upon RSU vesting.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Dallara Que
Role Chief Executive Officer
Type Security Shares Price Value
Tax Withholding Common Stock F1, F2 31,350 $18.15 $569K
Holdings After Transaction: Common Stock — 884,749 shares (Direct)
Footnotes (2)
  1. F1. Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs").
  2. F2. Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs.
Tax-withholding shares 31,350 shares Common Stock withheld on July 31, 2026 to satisfy RSU-related income tax obligations
Withholding price $18.15 per share Implied value per share for 31,350 shares withheld for income tax and remittance obligations
Direct holdings after transaction 884,749 shares Common Stock directly held by Dallara Que following the July 31, 2026 tax-withholding disposition, including shares issuable upon RSU vesting
Restricted Stock Units ("RSUs") financial
"in connection with the vesting and net settlement of Restricted Stock Units ("RSUs")."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
net settlement financial
"in connection with the vesting and net settlement of Restricted Stock Units"
income tax withholding and remittance obligations financial
"to satisfy income tax withholding and remittance obligations in connection with the vesting"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did MiniMed Group (MMED) disclose for Dallara Que?

MiniMed Group reported that CEO Dallara Que had 31,350 shares of Common Stock withheld for tax obligations. The shares were retained by the company to cover income taxes arising from the vesting and net settlement of Restricted Stock Units (RSUs), not sold in the open market.

At what price were MiniMed Group (MMED) shares withheld for Dallara Que’s taxes?

The withheld MiniMed Group shares were valued at $18.15 per share for tax-withholding purposes. This price applies to the 31,350 shares withheld by the company to satisfy income tax and remittance obligations tied to the vesting of Que’s RSUs.

How many MiniMed Group (MMED) shares does Dallara Que hold after the transaction?

After the tax-withholding event, Dallara Que directly holds 884,749 shares of MiniMed Group Common Stock. This figure includes shares that will be issued upon the vesting of one or more RSUs, as indicated in the footnote accompanying the filing.

Was Dallara Que’s MiniMed Group (MMED) transaction part of a 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 plan checkbox was not marked, and there is no footnote stating the transaction was made under a trading plan. The disposition reflects shares withheld by the issuer solely to meet RSU-related tax obligations.

Does the MiniMed Group (MMED) Form 4 reflect an open-market sale by the CEO?

No, the Form 4 reports a tax-withholding disposition, not an open-market sale. Shares were withheld by MiniMed Group to satisfy income tax and remittance obligations from the vesting and net settlement of RSUs awarded to CEO Dallara Que.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dallara Que

(Last)(First)(Middle)
C/O MINIMED GROUP, INC.
18000 DEVONSHIRE STREET

(Street)
NORTHRIDGE CALIFORNIA 91325

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/31/2026F31,350(1)D$18.15884,749(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs").
2. Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs.
Remarks:
/s/ Bryan F. Kelly, attorney-in-fact08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)